Celebrating the Life of Paul Leo Ray

Photos from Paul's Memorial Celebration

Photos of his "Lifetime Achievement Award" at BioWEST 2006

Paul "In his own words..." w3w3.com interviews

Send Paul, His Family and Friends a Message

..and heroes walk among us!

Heroes are important to the rest of us mere mortals.
By their example, they remind us of the high road, generosity, integrity, strength, and good will to all mankind, the "good life".

That describes our dear friend and hero, Paul Ray.
He passed from our lives Thursday January 4th, 2007.
We were fortunate to experience his spirit, his love and friendship. Memories of his great character will stay with us forever.

Among Paul's many talents, he was a great story teller. He made us laugh, he made us cry and he taught us so much. Larry and Paul were in the process of writing a book and we would like to include some of your comments and stories in the book. We invite you to join us and share your memories and stories.

Go to the w3w3 Blog and share your favorite moments.

Go to the w3w3 Blog
.. and share your favorite moments.

A Message from Paul sent, June 2006

     I hope that you do not feel that this email is too impersonal. Since being diagnosed with Lower Esophageal Cancer on March 24, 2006, as many of you already know, I have been undergoing chemo radiation at the Mayo Clinic in Scottsdale, AZ. I am now in week 3 of a 5 ½ week radiation protocol. The chemo protocol will continue until mid June. Somewhere around the end of July the reconstruction surgery takes place.

     Once upon a time I didn’t know that Gastro Esophageal Reflux Disease (GERD) is sweeping the world as an epidemic in its own right. As we baby boomers age, the years of stress, Pepto-Bismol, Rolaids, etc. are presenting more and more individuals such as myself to the oncology world.

     Some of you have successfully battled cancer, some are yet to do so, some will never experience this particular demon, but, as we all know, will encounter other challenges. I am learning to take everyday one day at a time and know that I am so fortunate compared to others I have met. Near term thinking is new ground for me as I have for many years planned months and years ahead.

     As a side note, as you know what a medical device guy I am, in each exam room at Mayo I have noted hanging on the wall are located the 6 instruments of basic diagnostics; a bright hand-held exam light, an Ophthalmoscope, an Otto-scope, a blood pressure cuff, a stethoscope and a thermometer. Not different from 100 years ago. It is the miracle of bio-therapeutic technologies that, many cases makes such a difference. Never the less, a treatment can only be as good as the diagnosis. It all starts with observation and comparison. Observe, evaluate and adjust accordingly.

Thanks for your thoughts and friendship.

Be diligent!

Paul

Paul in His Own Words – w3w3.com Radio Interviews (From 2003 – 2006) more..

   More of Paul in His Own Words…More Interviews You Can Listen to Anytime (Rocky Mountain News)

The CBSA’s Lifetime Achievement Award Presented to Mr. Paul Ray

Paul’s unwavering commitment to the Colorado biosciences industry, his participation in the public policy arena to promote the industry, his personal dedication to numerous start-up companies and his entrepreneurial energy were main factors in his selection.

Paul served as a gubernatorial appointee to the Colorado Advanced Technology Institute (CATI), the Governor’s Commission on Science and Technology and was named by the Colorado Secretary of Technology to the position of Director of Life Sciences and Biotechnology.

Additionally, Paul founded the Colorado Biomedical Venture Center (CBVC); a technology incubator and was a director for the University of Colorado Technology Corporation.  He currently serves on the statewide board as a director for CTEK and was a founding Board member of the Colorado BioScience Association.

Recently, he became the President and CEO of Surginetics, a Boulder-based electrosurgical company.  He has been an investor in several companies and previously held board positions with early-stage companies like AccuNetx and Evolutionary Genomics.